Ubiquigent Formed to Commercialize Products for Ubiquitylation Research
March 05, 2010
Ubiquigent Formed to Commercialize Products for Ubiquitylation Research
Ubiquigent is operating as a subsidiary of Stemgent, and will produce biological products and services generated by the Scottish Institute for Cell Signaling at the University of Dundee.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Samples Available for PRG 2012 Intra-Lab QC and Reproducibility Study
January 13, 2012 / ProteoMonitor - People in the News: Eric Bouvier; Alan Marshall; and More
January 13, 2012 / ProteoMonitor - NCI Kicks Off Second Stage of Clinical Proteomic Technologies for Cancer Initiative
August 26, 2011 / ProteoMonitor - Yale-Led Group Links Protein Markers to Kidney Injury in Cardiac Surgery Patients
August 26, 2011 / ProteoMonitor - Bio-Rad Develops More Sensitive, Streamlined Workflow for SPR-Mass Spec
August 26, 2011 / ProteoMonitor